Greenvolt Next has completed the development of a 4MW solar PV plant for biopharmaceutical Sanofi. Now in operation at Sanofi ...

Get all of the latest breaking local and international news stories as they happen, with up to the minute updates and analysis, from Ireland's National Broadcaster ...

Renewable energy solutions specialist Greenvolt Next, part of Greenvolt Group, has completed the development of a 4 MW solar PV plant for biopharmaceutical firm Sanofi in Co Waterford.

A new 4MW solar farm has been developed in Waterford for global biopharmaceutical company Sanofi. The project, which has been ...

A recently launched campaign starring patients and scientists shows Sanofi in hot pursuit of scientific innovation. Developed by the French drugmaker and WPP agencies GCI Health and VML, the corporate ...

Sanofi delivered strong Q3 results despite currency headwinds. The company's dependence on Dupixent is increasing. A broad immunology pipeline and the Blueprint Medicines acquisition should help ...

Sanofi is bestowing $625 million on its investment arm Sanofi Ventures, seeking to take advantage of a biotech landscape that is light on capital yet still heavy on scientific innovation. The cash ...

LONDON, Sept 4 (Reuters) - Shares in French drugmaker Sanofi (SASY.PA), opens new tab fell more than 10% on Thursday, wiping nearly $13 billion off its market value, after late-stage trial data for ...

French drugmaker Sanofi SA (NASDAQ:SNY) stock fell sharply Thursday after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Sanofi shares slid Thursday after the company reported underwhelming ...